This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geisbert, T. W.
Right arrow Articles by Jones, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geisbert, T. W.
Right arrow Articles by Jones, S. M.

 Previous Article  |  Next Article 

Journal of Virology, June 2008, p. 5664-5668, Vol. 82, No. 11
0022-538X/08/$08.00+0     doi:10.1128/JVI.00456-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates{triangledown}

Thomas W. Geisbert,1,2,3,4* Kathleen M. Daddario-DiCaprio,4,5 Kinola J. N. Williams,6 Joan B. Geisbert,1 Anders Leung,8 Friederike Feldmann,8 Lisa E. Hensley,5 Heinz Feldmann,7,8 and Steven M. Jones6,7,8

National Emerging Infectious Diseases Laboratories Institute,1 Department of Microbiology,2 Department of Medicine, Boston University School of Medicine, 715 Albany Street, Boston, Massachusetts,3 Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland,4 Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland,5 Department of Immunology,6 Medical Microbiology, University of Manitoba, 730 William Avenue, Winnipeg, Manitoba, Canada,7 Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, Manitoba, Canada8

Received 2 March 2008/ Accepted 21 March 2008

Recombinant vesicular stomatitis virus (VSV) vectors expressing homologous filoviral glycoproteins can completely protect rhesus monkeys against Marburg virus when administered after exposure and can partially protect macaques after challenge with Zaire ebolavirus. Here, we administered a VSV vector expressing the Sudan ebolavirus (SEBOV) glycoprotein to four rhesus macaques shortly after exposure to SEBOV. All four animals survived SEBOV challenge, while a control animal that received a nonspecific vector developed fulminant SEBOV hemorrhagic fever and succumbed. This is the first demonstration of complete postexposure protection against an Ebola virus in nonhuman primates and provides further evidence that postexposure vaccination may have utility in treating exposures to filoviruses.

* Corresponding author. Mailing address: Department of Microbiology, Boston University School of Medicine, 715 Albany Street, R514, Boston, MA 02118. Phone: (617) 638-4274. Fax: (617) 638-4286. E-mail: geisbert{at}bu.edu

{triangledown} Published ahead of print on 2 April 2008.

Journal of Virology, June 2008, p. 5664-5668, Vol. 82, No. 11
0022-538X/08/$08.00+0     doi:10.1128/JVI.00456-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Geisbert, T. W., Geisbert, J. B., Leung, A., Daddario-DiCaprio, K. M., Hensley, L. E., Grolla, A., Feldmann, H. (2009). Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus. J. Virol. 83: 7296-7304 [Abstract] [Full Text]  
  • Bente, D., Gren, J., Strong, J. E., Feldmann, H. (2009). Disease modeling for Ebola and Marburg viruses. DMM 2: 12-17 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»